Subventions financées

Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability, affecting 1 in 400 Canadian adults.

Decades of research suggest that obesity is a brain disease.

Glioblastoma (GBM) is the most common and deadly adult brain cancer.

Mental health disorders impact one in four Canadians, yet our understanding of the brain and its relationship to mental illness is dwarfed by what we do not know.

Glioblastoma is the most common primary malignant brain tumor in the adult population with a very poor prognostic.

Palliative care (PC) is an area of medicine that focuses on symptom control and quality of life of patients with life-limiting illnesses and their families.

Rodent models offer an opportunity to understand the computations performed in neural circuits at a much precise scale than using human neuroimaging.

Almost 9% of Canadians have ADHD, however it is likely higher as more girls and women are being diagnosed.

CAR-T therapies have delivered promising results for certain hematological cancers but remain largely ineffective for solid tumours with failure nodes including complex and hostile tumor microenvironments and the lack of adapted technological tools.

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating neurodegenerative diseases which have overlap in pathological features and the genetic basis.